ANIX (Anixa Biosciences) Days Sales Outstanding: (As of Jul. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ANIX Anixa Biosciences Inc ANIX
31 GF Score
Price $2.70
! 3 Warning Signs
View Full Analysis

What is Anixa Biosciences Days Sales Outstanding?

Anixa Biosciences's average Accounts Receivable for the three months ended in Jul. 2026 was $0.06 Mil. Anixa Biosciences's Revenue for the three months ended in Jul. 2026 was $0.00 Mil.

The historical rank and industry rank for Anixa Biosciences's Days Sales Outstanding or its related term are showing as below:

During the past 13 years, Anixa Biosciences's highest Days Sales Outstanding was 274.62. The lowest was 100.68. And the median was 273.02.

ANIX's Days Sales Outstanding is not ranked *
in the Biotechnology industry.
Industry Median: 69.01
* Ranked among companies with meaningful Days Sales Outstanding only.

Anixa Biosciences's Days Sales Outstanding stayed the same from Jul. 2025 () to Jul. 2026 ().

Anixa Biosciences  (NAS:ANIX) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Anixa Biosciences Days Sales Outstanding Related Terms

Anixa Biosciences Days Sales Outstanding Historical Data

* Premium members only.

The historical data trend for Anixa Biosciences's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Anixa Biosciences Days Sales Outstanding Chart

Anixa Biosciences Annual Data
Trend Oct16 Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23 Oct24 Oct25
Days Sales Outstanding
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.59 - 469.29 - -

Anixa Biosciences Quarterly Data
Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26 Jul26
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

ANIX vs GNLX, PMN, NTHI: Days Sales Outstanding Comparison

For the Biotechnology subindustry, Anixa Biosciences's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Anixa Biosciences Days Sales Outstanding vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Anixa Biosciences's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Anixa Biosciences's Days Sales Outstanding falls into.


ANIX
31GF Score
Anixa Biosciences Inc ANIX
Days Sales Outstanding is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Anixa Biosciences Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Anixa Biosciences's Days Sales Outstanding for the fiscal year that ended in Oct. 2025 is calculated as

Days Sales Outstanding (A: Oct. 2025 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Oct. 2024 ) + Accounts Receivable (A: Oct. 2025 )) / count ) / Revenue (A: Oct. 2025 )*Days in Period
=( (0.173 + 0) / 1 ) / 0*365
=0.173 / 0*365
=N/A

Anixa Biosciences's Days Sales Outstanding for the quarter that ended in Jul. 2026 is calculated as:

Days Sales Outstanding (Q: Jul. 2026 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Apr. 2026 ) + Accounts Receivable (A: Jul. 2026 )) / count ) / Revenue (A: Jul. 2026 )*Days in Period
=( (0.056 + ) / 1 ) / 0*365 / 4
=0.056 / 0*365 / 4
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Anixa Biosciences Business Description

Other Exchanges CY71:Germany
Address 3150 Almaden Expressway, Suite 250, San Jose, CA, USA, 95118
Anixa Biosciences Inc is a biotechnology company developing therapies and vaccines focused on critical unmet needs in oncology. Its operations are organized into reportable segments comprising Cancer Vaccines, CAR-T Therapies, and Other. The Cancer Vaccines segment involves vaccines to treat and prevent breast and ovarian cancer, as well as additional cancer vaccines targeting intractable cancers, including high-incidence malignancies in lung, colon, and prostate. The CAR-T Therapies segment involves the development of liraltagene autoleucel (lira-cel), an ovarian cancer immunotherapy using chimeric endocrine receptor-T cell technology, developed at its subsidiary, Certainty Therapeutics, Inc. The Other segment consists of legacy operations, including limited patent licensing activities.
31GF Score

Get the complete analysis for ANIX

Days Sales Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.70
Price